CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 55 filers reported holding CABALETTA BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,003 | +7.5% | 77,700 | -31.1% | 0.00% | 0.0% |
| Q1 2023 | $933 | -38.3% | 112,800 | -31.0% | 0.00% | -50.0% |
| Q4 2022 | $1,511 | -99.7% | 163,400 | -76.2% | 0.00% | +100.0% |
| Q3 2022 | $447,000 | +25.9% | 687,461 | +105.2% | 0.00% | – |
| Q2 2022 | $355,000 | -12.3% | 335,000 | +68.0% | 0.00% | – |
| Q1 2022 | $405,000 | +216.4% | 199,400 | +1238.3% | 0.00% | – |
| Q2 2021 | $128,000 | -81.3% | 14,900 | -75.8% | 0.00% | -100.0% |
| Q2 2020 | $685,000 | +621.1% | 61,447 | +372.7% | 0.00% | – |
| Q1 2020 | $95,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
| Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
| Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
| Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
| Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
| HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
| Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
| SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
| Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |